TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
TCL Archive NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study. June 3, 2005
TCL Archive Funding Opportunities: NCI Schedules Meeting on RFA For Pathology Informatics May 12, 2000
TCL Archive Central Oncology Group Phase Out Approved; Board Impressed By Unanimous CCIRC Vote April 2, 1976